Crispr Therapeutics shares tumble after significant earnings miss
Credo Technology Group Holding Ltd (NASDAQ:CRDO), a $16.9 billion technology company, saw its Chief Financial Officer Daniel W. Fleming sell a total of $368,733 in ordinary shares on July 10, 2025. The sales involved 3,790 shares sold at prices ranging from $96.78 to $97.96. The timing is notable as the stock trades near its 52-week high of $100.55, having delivered an impressive 220% return over the past year.
The transactions are detailed in a Form 4 filing with the Securities and Exchange Commission. The filing indicates that the sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted by Fleming on July 1, 2024. According to InvestingPro, the company maintains strong financial health with a current ratio of 6.62 and minimal debt levels.
Following the reported transactions, Fleming directly owns 582,428 ordinary shares of Credo Technology Group Holding Ltd. For deeper insights into insider trading patterns and comprehensive analysis of CRDO’s valuation metrics, InvestingPro subscribers can access the detailed Pro Research Report, available for over 1,400 US stocks.
In other recent news, Credo Technology Group Holding Ltd. reported a significant 25.9% increase in quarterly revenue, surpassing expectations by 6.3%, with non-GAAP earnings per share reaching $0.35. The company also posted strong free cash flow of $54.2 million. Credo’s revenue guidance midpoint is set at $190 million, marking an 11.7% quarter-over-quarter growth. Analysts at Stifel have raised the company’s stock price target to $80, maintaining a Buy rating due to the company’s robust financial performance and optimistic outlook. Mizuho (NYSE:MFG) also adjusted its price target for Credo Technology to $98, citing growth from data center trends and maintaining an Outperform rating. TD Cowen increased its price target to $95, recognizing Credo as a top pick in high-speed connectivity for datacenter AI applications. Noble Capital reiterated an Outperform rating with a $14 price target, highlighting the company’s compelling valuation compared to industry peers. These developments reflect Credo Technology’s strong market position and growth potential in the semiconductor industry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.